| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 136 | 60 | 3.859 | 5.172 | 5.044 | 4.962 | 4.872 | 4.885 | 4.263 | 0 |
| Gross Profit/Loss - EUR | -136 | -60 | -3.859 | -5.172 | -5.044 | -4.962 | -4.872 | -4.885 | -4.263 | 0 |
| Net Profit/Loss - EUR | -136 | -60 | -3.859 | -5.172 | -5.044 | -4.962 | -4.872 | -4.885 | -4.263 | 0 |
| Employees | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Arena Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 380.882 | 376.938 | 367.090 | 355.386 | 343.644 | 332.167 | 320.153 | 317.162 | 313.450 | 311.698 |
| Inventories | 108.534 | 107.427 | 105.610 | 103.671 | 101.664 | 99.736 | 97.525 | 97.827 | 97.531 | 96.986 |
| Receivables | 271.847 | 269.074 | 261.237 | 251.286 | 240.940 | 231.514 | 222.337 | 218.972 | 214.264 | 213.067 |
| Cash | 501 | 436 | 244 | 429 | 1.040 | 916 | 291 | 363 | 1.655 | 1.646 |
| Shareholders Funds | -4.674 | -4.686 | -8.465 | -13.482 | -18.266 | -22.881 | -27.246 | -32.216 | -36.381 | -36.177 |
| Social Capital | 67.492 | 66.803 | 65.673 | 64.468 | 63.219 | 62.021 | 60.645 | 60.833 | 60.649 | 60.310 |
| Debts | 385.556 | 381.624 | 375.556 | 368.868 | 361.909 | 355.048 | 347.399 | 349.378 | 349.831 | 347.876 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Arena Pharma Srl